Re-Expression of ... AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition. Lithium?
New study below [1]
Might interest those who have treatment-emergent loss of androgen receptor [AR].
"GSK-3 has been the subject of much research since it has been implicated in a number of diseases, including type 2 diabetes, Alzheimer's disease, inflammation, cancer, and bipolar disorder." [2]
"It
New study below [1]
Might interest those who have treatment-emergent loss of androgen receptor [AR].
"GSK-3 has been the subject of much research since it has been implicated in a number of diseases, including type 2 diabetes, Alzheimer's disease, inflammation, cancer, and bipolar disorder." [2]
"It